Autobio Diagnostics Co (SHSE:603658) EV-to-EBIT : 20.20 (As of May. 18, 2024)

View and export this data going back to 2016. Start your Free Trial

What is Autobio Diagnostics Co EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Autobio Diagnostics Co's Enterprise Value is ¥29,893 Mil. Autobio Diagnostics Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was ¥1,480 Mil. Therefore, Autobio Diagnostics Co's EV-to-EBIT for today is 20.20.

The historical rank and industry rank for Autobio Diagnostics Co's EV-to-EBIT or its related term are showing as below:

SHSE:603658' s EV-to-EBIT Range Over the Past 10 Years
Min: 18.6 Med: 39.94 Max: 85.33
Current: 20.35

During the past 13 years, the highest EV-to-EBIT of Autobio Diagnostics Co was 85.33. The lowest was 18.60. And the median was 39.94.

SHSE:603658's EV-to-EBIT is ranked better than
50.43% of 460 companies
in the Medical Devices & Instruments industry
Industry Median: 20.385 vs SHSE:603658: 20.35

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Autobio Diagnostics Co's Enterprise Value for the quarter that ended in Mar. 2024 was ¥32,629 Mil. Autobio Diagnostics Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was ¥1,480 Mil. Autobio Diagnostics Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 4.54%.

Autobio Diagnostics Co EV-to-EBIT Historical Data

The historical data trend for Autobio Diagnostics Co's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Autobio Diagnostics Co EV-to-EBIT Chart

Autobio Diagnostics Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-EBIT

Get a 7-Day Free Trial

45.19

74.86

29.55

26.91

23.14

Autobio Diagnostics Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-EBIT	Get a 7-Day Free Trial															27.26	23.28	20.89	23.14	22.05

Competitive Comparison of Autobio Diagnostics Co's EV-to-EBIT

For the Medical Devices subindustry, Autobio Diagnostics Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Autobio Diagnostics Co's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Autobio Diagnostics Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Autobio Diagnostics Co's EV-to-EBIT falls into.

Autobio Diagnostics Co EV-to-EBIT Calculation

Autobio Diagnostics Co's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	29893.135	/	1479.739
	=	20.20

Autobio Diagnostics Co's current Enterprise Value is ¥29,893 Mil.
Autobio Diagnostics Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1,480 Mil.

Autobio Diagnostics Co (SHSE:603658) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Autobio Diagnostics Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 )	=	EBIT	/	Enterprise Value (Q: Mar. 2024 )
	=	1479.739	/	32628.81368
	=	4.54 %

Autobio Diagnostics Co's Enterprise Value for the quarter that ended in Mar. 2024 was ¥32,629 Mil.
Autobio Diagnostics Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1,480 Mil.

Autobio Diagnostics Co EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Autobio Diagnostics Co's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Autobio Diagnostics Co (SHSE:603658) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Autobio Diagnostics Co Ltd (SHSE:603658) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.199, 15th Avenue, National Economic and Technological Development Area, Zhengzhou, CHN, 450016

Website

http://www.autobio.com.cn

Autobio Diagnostics Co Ltd is a clinical diagnostics company in China. It specializes in research and development, production, marketing and service of clinical diagnostic products, including immunoassay, microbiology and biochemical products. It focuses on the common development of both reagents and instruments. Reagents products include immunoassay, biochemistry, microbiology, and IVD subdivision areas, and instruments include both full automation and semi-automation instruments and systems. Geographically it holds a strong distribution network with thousands of distributors in the Chinese market.

Autobio Diagnostics Co (SHSE:603658) Headlines

No Headlines